Locktacs for Intrinsically Disordered Proteins: First-in-Class p27 Molecular Glue Stabilizers

• First-in-class p27 molecular glue addressing CDK4/6 & CDK2 resistance
• Differentiated molecular glue mechanism resetting cell-cycle control
• Scalable platform unlocking a pipeline of historically “undruggable” oncology drivers

Speakers:

Stacy Blain

Chief Executive Officer & Founder

Concarlo Holdings LLC